Why do doctors recommend TEVA’s Shared Solutions®?

Stuart SchlossmanAdditional MS resource sites

COPAXONE®
Why do doctors
recommend TEVA’s Shared Solutions®?
It is getting the patient started on treatment; it is dealing with insurance issues; it is reviewing with the patient payment issues; co-pays...
Doctors have
been compensated by Teva Neuroscience, Inc.
Hear From Doctors Now
Experience the
freedom of injection-free weekends,* with 3-times-a-week COPAXONE®
(glatiramer acetate injection) 40 mg

*Injections
must be at least 48 hours apart.

Why Teva’s COPAXONE®?
  • The #1
    prescribed brand for relapsing MS in the US1 †
  • Demonstrated
    safety and tolerability profile; proven effectiveness
    Based on
    total number of prescriptions for relapsing forms of MS (IMS
    National Rx Audit, June 2015).
Why Teva’s
Shared Solutions®?
  • A network
    of support offering a full breadth of personalized services to
    help patients achieve their relapsing MS management goals
  • Through
    COPAXONE Co-pay Solutions®, if eligible, your co-pay
    for 3-times-a-week COPAXONE® 40 mg, could be lowered to
    $0 per month out of pocket. Terms and conditions
    apply.
Learn more
about Teva’s COPAXONE® and Shared Solutions®
Visit COPAXONE.com
COPAXONE®
COPAXONE® is
indicated for the treatment of patients with relapsing forms
of multiple sclerosis.

 

Important Safety Information 


Do not take COPAXONE® if you are
allergic to glatiramer acetate or mannitol.

Some patients report a short-term reaction right after injecting
COPAXONE®. This reaction can involve flushing (feeling of
warmth and/or redness), chest tightness or pain with heart
palpitations, anxiety, and trouble breathing. These symptoms
generally appear within minutes of an injection, last about 15
minutes, and do not require specific treatment. During the
postmarketing period, there have been reports of patients with
similar symptoms who received emergency medical care. If symptoms become
severe, call the emergency phone number in your area. 
Call
your doctor right away if you develop hives, skin rash with
irritation, dizziness, sweating, chest pain, trouble breathing, or
severe pain at the injection site. If any of the above occurs, do not
give yourself any more injections until your doctor tells you to
begin again.

Chest pain may occur either as part of the immediate postinjection
reaction or on its own. This pain should only last a few minutes. You
may experience more than one such episode, usually beginning at least
one month after starting treatment. Tell your doctor if you
experience chest pain that lasts for a long time or feels very
intense.

A permanent indentation under the skin (lipoatrophy or, rarely,
necrosis) at the injection site may occur, due to local destruction
of fat tissue. Be sure to follow proper injection technique and
inform your doctor of any skin changes.

The most common side effects in studies of COPAXONE® are
redness, pain, swelling, itching, or a lump at the site of injection,
flushing, rash, shortness of breath, and chest pain. These are not
all of the possible side effects of COPAXONE®. For a
complete list, ask your doctor or pharmacist. Tell your doctor about
any side effects you have while taking COPAXONE®.

You are encouraged to report negative side effects of prescription
drugs to the FDA. Visit www.fda.gov/medwatch or call
1-800-FDA-1088.

Please see
full 
Prescribing Information.

Reference: 1. IMS Health National Prescription Audit,
June 2015. Data proprietary to IMS Health.


Applies only to 3-times-a-week COPAXONE® 40 mg. Certain
limits and restrictions apply. Terms and Conditions include: COPAXONE
Co-pay Solutions® is open to both new and existing patients
who are residents of the US or Puerto Rico and who have commercial
prescription insurance coverage for COPAXONE® 40 mg. The
offer is not valid for uninsured patients or patients covered in whole
or in part by Medicaid, Medicare, TRICARE, or any other federal or
state government pharmaceutical assistance plan or program (regardless
of whether a specific prescription is covered), or by private health
benefit programs that reimburse for the entire cost of prescription drugs.
Use of this offer must be consistent with the terms of any drug benefit
provided by a health insurer, health plan, or private third-party
payor. This offer is void where prohibited by law, taxed, or
restricted. No additional purchase is required. This offer is valid
only at participating pharmacies and may be changed or discontinued at
any time without notice. This program is not health insurance.

COPAXONE®
and COPAXONE CO-PAY SOLUTIONS® are registered trademarks of
Teva Pharmaceutical Industries Ltd.
Shared Solutions® is a registered service mark of Teva
Neuroscience, Inc.
© 2015 Teva Neuroscience, Inc. COP-43034

Teva Neuroscience, Inc., COPAXONE® Marketing, 11100 Nall
Avenue, Overland Park, KS 66211

Teva Neuroscience 
Teva Shared Solutions
This e-mail
was sent from MultipleSclerosis.net,
a property of Health Union, LLC, 1 International Plaza, Suite 550
Philadelphia, PA 19113. To unsubscribe, click here.

© 2015 Health
Union. All rights reserved. This information is not designed to replace
a physician’s independent judgment about the appropriateness or risks
of a procedure for a given patient. Always consult your doctor about
your medical conditions. MultipleSclerosis.net does not provide medical
advice, diagnosis or treatment. Use of the site is conditional upon
your acceptance of our terms of use.

Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews